Advancing Climate Action, Governance Excellence, and Global Scientific ImpactPISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental ...
The collaboration pairs Mimulus's molecular architecture with GenScript's massive synthesis scale to liberate critical grid power for AI compute and launch the "Forever Archive" for enterprise data ...
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...
Good day, and thank you for standing by. Welcome to Genscript 2025 Annual Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like ...
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by ...
Jefferies analyst Cui Cui maintained a Buy rating on Genscript Biotech on April 3 and set a price target of HK$15.50. Cui covers the Healthcare sector, focusing on stocks such as Genscript Biotech, ...
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, ...
PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental ...
The 2025 ESG Report underscores GenScript’s continued focus on aligning business growth with responsible practices. At a time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results